BCL2 and cancer: Aberrant activation of STAT3 signaling participates in the initiation, development and progression of human cancers via induction of STAT3 downstream genes that encode antiapoptotic proteins, cell cycle regulators and angiogenic factors such as Bcl-2, Cyclin D1 and VEGF [47].